€84.0M
The round was led by Kurma Growth Opportunities Fund, Angelini Ventures, Wellington Partners, and Neva SGR.
Portfolio
3
companies
Nuclidium
Nuclidium builds copper-based radiopharmaceuticals for precision cancer diagnosis and treatment.
Onfido
Onfido provides digital identity verification and authentication through artificial intelligence.

Quanta Dialysis Technologies
Quanta Dialysis Technologies provides compact dialysis systems for clinical and home use.
The round was led by Kurma Growth Opportunities Fund, Angelini Ventures, Wellington Partners, and Neva SGR.

The financing round was led by Glenview Capital and co-led by Novo Holdings.
"Everybody knows that dialysis care must improve. For this to happen, providers and physicians need products that allow greater flexibility to bring dialysis directly to the patient, while simplifying complexity and reducing the overall cost of care. Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care. The funding we are announcing today will allow us to accelerate our emergence as a significant force in this market."
The Series C financing was led by SBI Investment and Salesforce Ventures to support international expansion and product development.
"We chose to invest in Onfido because they have proven their expertise at using artificial intelligence to effectively fight fraud, giving businesses a safe and secure way to scale their businesses online."